ReYuu Japan Inc. (9425) AI Stock Analysis

• Market Cap: ¥4.37B
• Dividend Yield: N/A
• Average Volume (3M): 1.73M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.84
• Revenue Growth: 15.62%
• EPS Growth: -136.28%
• Country: JP
• Employees: 71
• Sector: Technology
• Sector Strength: 88
• Industry: Specialty Retail
• EPS (TTM): N/A
• Shares Outstanding: 6,990,400
• 10 Day Avg. Volume: 393,660
• 30 Day Avg. Volume: 1,729,030
• PEG Ratio: -2.32
• Price to Book (P/B): 1.94
• Price to Sales (P/S): 0.36
• P/FCF Ratio: -2.28
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: ¥635.00 ▼(-1.09% Downside)

ReYuu Japan Inc.'s overall stock score is primarily impacted by its financial performance, which shows significant challenges in profitability and cash flow. Technical analysis suggests a mixed outlook with some short-term support but overall bearish trends. Valuation metrics are weak due to negative earnings and lack of dividends, further weighing down the score.

ReYuu Japan Inc. Business Overview & Revenue Model

Company Description

ReYuu Japan Inc. (9425) is a technology-driven company based in Japan that specializes in providing innovative solutions within the healthcare and wellness sectors. The company focuses on leveraging advanced technologies to develop products and services that enhance patient care, streamline medical operations, and promote overall health and wellness. Its core offerings include electronic health record systems, telemedicine platforms, and wellness applications aimed at both healthcare providers and consumers.

How the Company Makes Money

ReYuu Japan Inc. generates revenue primarily through the sale of its software solutions and services to healthcare institutions, including hospitals and clinics. The company also earns income from subscription fees for its telemedicine and wellness platforms, which provide ongoing access to its services for healthcare providers and patients. Additionally, ReYuu may collaborate with pharmaceutical companies and health insurance providers to create integrated solutions, which can contribute to its revenue through strategic partnerships and joint ventures. Furthermore, the company may explore research and development grants or funding opportunities to support its innovative projects, enhancing its overall earning potential.

ReYuu Japan Inc. Financial Statement Overview

Summary

ReYuu Japan Inc. faces financial difficulties, with declining profitability and cash flow challenges. While revenue growth is positive, operational inefficiencies and negative cash flows pose risks. The balance sheet remains moderately leveraged, but improving profitability and cash flow is crucial for stability.

Income Statement

ReYuu Japan Inc. has experienced a challenging period with declining profitability. The gross profit margin is 10.17%, and the net profit margin is -1.82%, indicating losses. Revenue growth is positive at 15.72% from the previous year, but EBIT and EBITDA margins are negative, reflecting operational inefficiencies.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio of 1.01, suggesting balanced leverage. However, the return on equity is negative at -9.94%, due to net losses. The equity ratio stands at 45.90%, indicating a reasonable level of equity financing.

Cash Flow

Cash flow analysis reveals significant challenges, with a negative operating cash flow to net income ratio, indicating cash flow issues. Free cash flow is also negative, and the free cash flow to net income ratio is unfavorable. The company needs to improve cash generation to support operations.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.73B	4.09B	3.10B	5.46B	5.69B
Gross Profit	481.46M	452.62M	530.33M	750.06M	834.10M
EBITDA	-60.16M	-64.74M	-337.06M	-187.77M	72.93M
Net Income	-86.16M	-81.00M	-356.20M	-228.49M	65.16M
Balance Sheet
Total Assets	1.89B	1.92B	1.57B	1.89B	1.23B
Cash, Cash Equivalents and Short-Term Investments	411.18M	1.09B	665.46M	1.10B	541.52M
Total Debt	876.67M	713.34M	153.47M	187.08M	240.95M
Total Liabilities	1.02B	865.66M	440.03M	577.37M	532.43M
Stockholders Equity	866.46M	1.05B	1.13B	1.31B	700.08M
Cash Flow
Free Cash Flow	-737.16M	-393.46M	-398.90M	-207.14M	-97.12M
Operating Cash Flow	-737.16M	-381.05M	-396.91M	-207.14M	-76.60M
Investing Cash Flow	-6.03M	245.82M	-9.88M	-161.00K	12.62M
Financing Cash Flow	63.98M	560.16M	-33.56M	766.19M	102.62M

ReYuu Japan Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 642.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9425, the sentiment is Negative. The current price of 642 is above the 20-day moving average (MA) of 639.60, below the 50-day MA of 725.26, and above the 200-day MA of 594.40, indicating a neutral trend. The MACD of -12.63 indicates Negative momentum. The RSI at 46.60 is Neutral, neither overbought nor oversold. The STOCH value of 54.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9425.

ReYuu Japan Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3177	80 Outperform	¥3.11B	6.88	―	3.71%	5.53%	9.08%
3181	77 Outperform	¥3.09B	10.03	―	1.16%	24.10%	-15.55%
3138	74 Outperform	¥3.62B	58.58	―	1.40%	1.26%	-74.85%
3195	63 Neutral	¥5.71B	-80.95	―	―	5.54%	-512.01%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
9425	46 Neutral	¥4.37B	-12.85	―	―	15.62%	-136.28%
9557	46 Neutral	¥2.87B	116.64	―	―	17.59%	―